{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:00:54Z","timestamp":1773691254237,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00115-018-0486-4","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T08:30:41Z","timestamp":1517301041000},"page":"666-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuromyelitis-optica-Spektrum-Erkrankung und Schwangerschaft","Neuromyelitis optica spectrum disorder and pregnancy"],"prefix":"10.1007","volume":"89","author":[{"given":"N.","family":"Borisow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"486_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1352458515581438","volume":"22","author":"H Abboud","year":"2016","unstructured":"Abboud H, Petrak A, Mealy M et\u00a0al (2016) Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler 22:185\u2013192. \n                    https:\/\/doi.org\/10.1177\/1352458515581438","journal-title":"Mult Scler"},{"key":"486_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.transci.2010.05.002","volume":"43","author":"K Abou-Nassar","year":"2010","unstructured":"Abou-Nassar K, Karsh J, Giulivi A, Allan D (2010) Successful prevention of thrombotic thrombocytopenic purpura (TTP) relapse using monthly prophylactic plasma exchanges throughout pregnancy in a\u00a0patient with systemic lupus erythematosus and a\u00a0prior history of refractory TTP and recurrent fetal loss. Transfus Apher Sci 43:29\u201331. \n                    https:\/\/doi.org\/10.1016\/j.transci.2010.05.002","journal-title":"Transfus Apher Sci"},{"key":"486_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2017.06.006","author":"Z Alami","year":"2017","unstructured":"Alami Z, Agier MS, Ahid S et\u00a0al (2017) Pregnancy outcome following in utero exposure to azathioprine: a French comparative observational study. Therapie. \n                    https:\/\/doi.org\/10.1016\/j.therap.2017.06.006","journal-title":"Therapie"},{"key":"486_CR4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","volume":"82","author":"M Araki","year":"2014","unstructured":"Araki M, Matsuoka T, Miyamoto K et al (2014) Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a\u00a0pilot study. Neurology 82:1302\u20131306. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000317","journal-title":"Neurology"},{"key":"486_CR5","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1212\/NXI.0000000000000343","volume":"4","author":"N Asgari","year":"2017","unstructured":"Asgari N, Flanagan EP, Fujihara K et\u00a0al (2017) Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 4:e343. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000343","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR6","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1212\/NXI.0000000000000104","volume":"2","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, O\u2019Connor KC, Bar-Or A et al (2015) B lymphocytes in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm 2:e104. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000104","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, de Seze J, Lana-Peixoto M et al (2015) Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography. Mult Scler 21:678\u2013688. \n                    https:\/\/doi.org\/10.1177\/1352458514567216","journal-title":"Mult Scler"},{"key":"486_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","volume":"26","author":"BL Bermas","year":"2014","unstructured":"Bermas BL (2014) Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Curr Opin Rheumatol 26:334\u2013340. \n                    https:\/\/doi.org\/10.1097\/BOR.0000000000000054","journal-title":"Curr Opin Rheumatol"},{"key":"486_CR9","volume-title":"Intraven\u00f6se Immunglobuline bei der Multiplen Sklerose","author":"bfarm","year":"2018","unstructured":"bfarm (2018) Intraven\u00f6se Immunglobuline bei der Multiplen Sklerose. \n                    http:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Zulassung\/BereitsZugelAM\/offlabel\/Bewertungen\/Neuro\/IVIG_MS.pdf\n                    \n                  . Zugegriffen: 24. Aug. 2017"},{"key":"486_CR10","doi-asserted-by":"publisher","first-page":"787630","DOI":"10.1155\/2012\/787630","volume":"2012","author":"M Bonnan","year":"2012","unstructured":"Bonnan M, Cabre P (2012) Plasma exchange in severe attacks of neuromyelitis optica. Mult Scler Int 2012:787630. \n                    https:\/\/doi.org\/10.1155\/2012\/787630","journal-title":"Mult Scler Int"},{"key":"486_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1191\/096120399678847696","volume":"8","author":"F Bonnet","year":"1999","unstructured":"Bonnet F, Merci\u00e9 P, Morlat P et\u00a0al (1999) Devic\u2019s neuromyelitis optica during pregnancy in a\u00a0patient with systemic lupus erythematosus. Lupus 8:244\u2013247. \n                    https:\/\/doi.org\/10.1191\/096120399678847696","journal-title":"Lupus"},{"key":"486_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jca.21229","volume":"27","author":"A Bontadi","year":"2012","unstructured":"Bontadi A, Ruffatti A, Marson P et\u00a0al (2012) Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J\u00a0Clin Apher 27:200\u2013204. https:\/\/doi.org\/10.1002\/jca\u00a0.21229","journal-title":"J Clin Apher"},{"key":"486_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1878-5085-3-9","volume":"3","author":"N Borisow","year":"2012","unstructured":"Borisow N, D\u00f6ring A, Pfueller CF et\u00a0al (2012) Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA J 3:9. \n                    https:\/\/doi.org\/10.1186\/1878-5085-3-9","journal-title":"EPMA J."},{"key":"486_CR14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/1352458516671203","volume":"23","author":"N Borisow","year":"2017","unstructured":"Borisow N, Kleiter I, Gahlen A et\u00a0al (2017) Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. Mult Scler 23:1092\u20131103. \n                    https:\/\/doi.org\/10.1177\/1352458516671203","journal-title":"Mult Scler"},{"key":"486_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","volume":"78","author":"B Bourre","year":"2012","unstructured":"Bourre B, Marignier R, Z\u00e9phir H et\u00a0al (2012) Neuromyelitis optica and pregnancy. Neurology 78:875\u2013879. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31824c466f","journal-title":"Neurology"},{"key":"486_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000339","author":"R Bove","year":"2017","unstructured":"Bove R, Elsone L, Alvarez E et\u00a0al (2017) Female hormonal exposures and neuromyelitis optica symptom onset in a\u00a0multicenter study. Neurol Neuroimmunol Neuroinflamm. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000339","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/gut.2010.222893","volume":"60","author":"J Coelho","year":"2011","unstructured":"Coelho J, Beaugerie L, Colombel JF et\u00a0al (2011) Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 60:198\u2013203. \n                    https:\/\/doi.org\/10.1136\/gut.2010.222893","journal-title":"Gut"},{"key":"486_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJM199807303390501","volume":"339","author":"C Confavreux","year":"1998","unstructured":"Confavreux C, Hutchinson M, Hours MM et al (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N\u00a0Engl J Med 339:285\u2013291. \n                    https:\/\/doi.org\/10.1056\/NEJM199807303390501","journal-title":"N Engl J Med"},{"key":"486_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jca.21468","volume":"32","author":"JL Cox","year":"2017","unstructured":"Cox JL, Koepsell SA, Shunkwiler SM (2017) Therapeutic plasma exchange and pregnancy: a case report and guidelines for performing plasma exchange in a\u00a0pregnant patient. J\u00a0Clin Apher 32:191\u2013195. https:\/\/doi.org\/10.1002\/jca\u00a0.21468","journal-title":"J Clin Apher"},{"key":"486_CR20","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1212\/NXI.0000000000000288","volume":"3","author":"V Davoudi","year":"2016","unstructured":"Davoudi V, Keyhanian K, Bove RM, Chitnis T (2016) Immunology of neuromyelitis optica during pregnancy. Neurol Neuroimmunol Neuroinflamm 3:e288. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000288","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0022-3476(84)80435-7","volume":"105","author":"DB DeWitte","year":"1984","unstructured":"DeWitte DB, Buick MK, Cyran SE, Maisels MJ (1984) Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J\u00a0Pediatr 105:625\u2013628","journal-title":"J Pediatr"},{"key":"486_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijgo.2007.05.045","volume":"99","author":"DO El-Haieg","year":"2007","unstructured":"El-Haieg DO, Zanati MF, El-Foual FM (2007) Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome. Int J Gynaecol Obstet 99:236\u2013241. \n                    https:\/\/doi.org\/10.1016\/j.ijgo.2007.05.045","journal-title":"Int J Gynaecol Obstet"},{"key":"486_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1352458513495938","volume":"20","author":"L Elsone","year":"2014","unstructured":"Elsone L, Panicker J, Mutch K et\u00a0al (2014) Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients. Mult Scler 20:501\u2013504. \n                    https:\/\/doi.org\/10.1177\/1352458513495938","journal-title":"Mult Scler"},{"key":"486_CR24","unstructured":"Embryotox (2017) http\/\/\n                    www.embyotox.de\n                    \n                  . Zugegriffen: 24. Aug. 2017"},{"key":"486_CR25","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1007\/s00415-013-7031-y","volume":"260","author":"YD Fragoso","year":"2013","unstructured":"Fragoso YD, Adoni T, Bichuetti DB et\u00a0al (2013) Neuromyelitis optica and pregnancy. J\u00a0Neurol 260:2614\u20132619. \n                    https:\/\/doi.org\/10.1007\/s00415-013-7031-y","journal-title":"J Neurol"},{"key":"486_CR26","first-page":"1426","volume":"91","author":"B Friedrichs","year":"2006","unstructured":"Friedrichs B, Tiemann M, Salwender H et\u00a0al (2006) The effects of rituximab treatment during pregnancy on a\u00a0neonate. Haematologica 91:1426\u20131427","journal-title":"Haematologica"},{"key":"486_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1352458515586084","volume":"22","author":"L Hertwig","year":"2016","unstructured":"Hertwig L, Pache F, Romero-Suarez S et al (2016) Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica. Mult Scler 22:160\u2013173. \n                    https:\/\/doi.org\/10.1177\/1352458515586084","journal-title":"Mult Scler"},{"key":"486_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semarthrit.2016.05.004","volume":"46","author":"M Hoeltzenbein","year":"2016","unstructured":"Hoeltzenbein M, Beck E, Rajwanshi R et al (2016) Tocilizumab use in pregnancy: analysis of a\u00a0global safety database including data from clinical trials and post-marketing data. Semin Arthritis Rheum 46:238\u2013245. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2016.05.004","journal-title":"Semin Arthritis Rheum"},{"key":"486_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00115-014-4239-8","volume":"86","author":"F Hoffmann","year":"2015","unstructured":"Hoffmann F, Kraft A, Heigl F et\u00a0al (2015) Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding. Nervenarzt 86:179\u2013186. \n                    https:\/\/doi.org\/10.1007\/s00115-014-4239-8","journal-title":"Nervenarzt"},{"key":"486_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0719-z","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. J\u00a0Neuroinflammation 13(281). \n                    https:\/\/doi.org\/10.1186\/s12974-016-0719-z","journal-title":"J Neuroinflammation"},{"key":"486_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202\u2013214. \n                    https:\/\/doi.org\/10.1038\/ncpneuro0764","journal-title":"Nat Clin Pract Neurol"},{"key":"486_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J\u00a0Neuroinflammation 13:279. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0717-1","journal-title":"J Neuroinflammation"},{"key":"486_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J\u00a0Neuroinflammation 13:280. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"486_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B et\u00a0al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J\u00a0Neuroinflammation 9:14. \n                    https:\/\/doi.org\/10.1186\/1742-2094-9-14","journal-title":"J Neuroinflammation"},{"key":"486_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149\u2013164. \n                    https:\/\/doi.org\/10.1111\/cei.12271","journal-title":"Clin Exp Immunol"},{"key":"486_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/gutjnl-2012-303615","volume":"63","author":"B Jharap","year":"2014","unstructured":"Jharap B, de Boer NKH, Stokkers P et\u00a0al (2014) Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 63:451\u2013457. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2012-303615","journal-title":"Gut"},{"key":"486_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clineuro.2014.12.023","volume":"130","author":"A Jurewicz","year":"2015","unstructured":"Jurewicz A, Selmaj K (2015) Relapse of neuromyelitis optica during pregnancy\u2014treatment options and literature review. Clin Neurol Neurosurg 130:159\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.clineuro.2014.12.023","journal-title":"Clin Neurol Neurosurg"},{"key":"486_CR38","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","volume":"78","author":"W Kim","year":"2012","unstructured":"Kim W, Kim S\u2011H, Nakashima I et al (2012) Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology 78:1264\u20131267. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318250d812","journal-title":"Neurology"},{"key":"486_CR39","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1212\/WNL.0000000000004681","volume":"89","author":"E Klawitter","year":"2017","unstructured":"Klawitter E, Bove R, Elsone L et al (2017) High risk of post-partum relapses in neuromyelitis optica spectrum disorder. Neurology 89:2238. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004681","journal-title":"Neurology"},{"key":"486_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24554","volume":"79","author":"I Kleiter","year":"2016","unstructured":"Kleiter I, Gahlen A, Borisow N et\u00a0al (2016) Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 79:206\u2013216. \n                    https:\/\/doi.org\/10.1002\/ana.24554","journal-title":"Ann Neurol"},{"key":"486_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/271363","author":"DT Klink","year":"2008","unstructured":"Klink DT, van Elburg RM, Schreurs MWJ, van Well GTJ (2008) Rituximab administration in third trimester of pregnancy suppresses neonatal B\u2011cell development. Clin Dev Immunol. \n                    https:\/\/doi.org\/10.1155\/2008\/271363","journal-title":"Clin Dev Immunol"},{"key":"486_CR42","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1212\/NXI.0000000000000335","volume":"4","author":"P K\u00f6rtv\u00e9lyessy","year":"2017","unstructured":"K\u00f6rtv\u00e9lyessy P, Breu M, Pawlitzki M et al (2017) ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports. Neurol Neuroimmunol Neuroinflamm 4:e335. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000335","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/1352458513507822","volume":"20","author":"L Kremer","year":"2014","unstructured":"Kremer L, Mealy M, Jacob A et\u00a0al (2014) Brainstem manifestations in neuromyelitis optica: a\u00a0multicenter study of 258 patients. Mult Scler 20:843\u2013847. \n                    https:\/\/doi.org\/10.1177\/1352458513507822","journal-title":"Mult Scler"},{"key":"486_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nrl.2012.03.014","volume":"28","author":"MJ Magraner","year":"2013","unstructured":"Magraner MJ, Coret F, Casanova B (2013) The effect of intravenous immunoglobulin on neuromyelitis optica. Neurologia 28:65\u201372. \n                    https:\/\/doi.org\/10.1016\/j.nrl.2012.03.014","journal-title":"Neurologia"},{"key":"486_CR45","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1212\/NXI.0000000000000204","volume":"3","author":"I Metz","year":"2016","unstructured":"Metz I, Bei\u00dfbarth T, Ellenberger D et\u00a0al (2016) Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e204. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000204","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3109\/14397595.2016.1147405","volume":"26","author":"K Nakajima","year":"2016","unstructured":"Nakajima K, Watanabe O, Mochizuki M et\u00a0al (2016) Pregnancy outcomes after exposure to tocilizumab: a retrospective analysis of 61 patients in Japan. Mod Rheumatol 26:667\u2013671. \n                    https:\/\/doi.org\/10.3109\/14397595.2016.1147405","journal-title":"Mod Rheumatol"},{"key":"486_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-0897.1999.tb00443.x","volume":"41","author":"Y Nakamura","year":"1999","unstructured":"Nakamura Y, Yoshida K, Itoh S et\u00a0al (1999) Immunoadsorption plasmapheresis as a\u00a0treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies. Am J Reprod Immunol 41:307\u2013311","journal-title":"Am J Reprod Immunol"},{"key":"486_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","volume":"86","author":"MM Nour","year":"2016","unstructured":"Nour MM, Nakashima I, Coutinho E et al (2016) Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder. Neurology 86:79\u201387. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002208","journal-title":"Neurology"},{"key":"486_CR49","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2169\/internalmedicine.46.0217","volume":"46","author":"K Okada","year":"2007","unstructured":"Okada K, Tsuji S, Tanaka K (2007) Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica. Intern Med 46:1671\u20131672","journal-title":"Intern Med"},{"key":"486_CR50","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0035-1567186","volume":"85","author":"F Pache","year":"2017","unstructured":"Pache F, Wildemann B, Paul F, Jarius S (2017) Neuromyelitis optica. Fortschr Neurol Psychiatr 85:e1. \n                    https:\/\/doi.org\/10.1055\/s-0035-1567186","journal-title":"Fortschr Neurol Psychiatr"},{"key":"486_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","volume":"13","author":"F Pache","year":"2016","unstructured":"Pache F, Zimmermann H, Mikolajczak J et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J\u00a0Neuroinflammation 13:282. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0720-6","journal-title":"J Neuroinflammation"},{"key":"486_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Asgari N, Apiwattanakul M et\u00a0al (2015) Demographic and clinical features of neuromyelitis optica: a review. Mult Scler 21:845\u2013853. \n                    https:\/\/doi.org\/10.1177\/1352458515572406","journal-title":"Mult Scler"},{"key":"486_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie L, Mazzotta P, Pastuszak A et al (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385\u2013392. https:\/\/doi.org\/10.1002\/1096-9926(200012)62:6\u3008385::AID-TERA5\u30093.0.CO;2-Z","journal-title":"Teratology"},{"key":"486_CR54","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1177\/1352458509106512","volume":"15","author":"HL Pellkofer","year":"2009","unstructured":"Pellkofer HL, Suessmair C, Schulze A et\u00a0al (2009) Course of neuromyelitis optica during inadvertent pregnancy in a\u00a0patient treated with rituximab. Mult Scler 15:1006\u20131008. \n                    https:\/\/doi.org\/10.1177\/1352458509106512","journal-title":"Mult Scler"},{"key":"486_CR55","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF et\u00a0al (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964\u2013968. \n                    https:\/\/doi.org\/10.1001\/archneur.63.7.964","journal-title":"Arch Neurol"},{"key":"486_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/bdra.23509","volume":"106","author":"AV Plauborg","year":"2016","unstructured":"Plauborg AV, Hansen AV, Garne E (2016) Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease. Birth Defects Res Part A Clin Mol Teratol 106:494\u2013499. \n                    https:\/\/doi.org\/10.1002\/bdra.23509","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"486_CR57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00277-001-0426-3","volume":"81","author":"A Proia","year":"2002","unstructured":"Proia A, Paesano R, Torcia F et\u00a0al (2002) Thrombotic thrombocytopenic purpura and pregnancy: a\u00a0case report and a\u00a0review of the literature. Ann Hematol 81:210\u2013214. \n                    https:\/\/doi.org\/10.1007\/s00277-001-0426-3","journal-title":"Ann Hematol"},{"key":"486_CR58","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1212\/NXI.0000000000000060","volume":"2","author":"M Reindl","year":"2015","unstructured":"Reindl M, Rostasy K (2015) MOG antibody-associated diseases. Neurol Neuroimmunol Neuroinflamm 2:e60. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000060","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR59","doi-asserted-by":"publisher","first-page":"b4026","DOI":"10.1136\/bmj.b4026","volume":"339","author":"R Reuss","year":"2009","unstructured":"Reuss R, Rommer PS, Br\u00fcck W et\u00a0al (2009) A woman with acute myelopathy in pregnancy: case outcome. BMJ 339:b4026","journal-title":"BMJ"},{"key":"486_CR60","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","volume":"72","author":"M Ringelstein","year":"2015","unstructured":"Ringelstein M, Ayzenberg I, Harmel J et al (2015) Long-term therapy with Interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder. JAMA Neurol 72:756\u2013763. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2015.0533","journal-title":"JAMA Neurol"},{"key":"486_CR61","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1177\/1352458513498125","volume":"19","author":"M Ringelstein","year":"2013","unstructured":"Ringelstein M, Harmel J, Distelmaier F et al (2013) Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Mult Scler 19:1544\u20131547. \n                    https:\/\/doi.org\/10.1177\/1352458513498125","journal-title":"Mult Scler"},{"key":"486_CR62","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","volume":"191","author":"S Saadoun","year":"2013","unstructured":"Saadoun S, Waters P, Leite MI et\u00a0al (2013) Neuromyelitis optica IgG causes placental inflammation and fetal death. J\u00a0Immunol 191:2999\u20133005. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1301483","journal-title":"J Immunol"},{"key":"486_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.msard.2016.11.008","volume":"11","author":"F Schmidt","year":"2017","unstructured":"Schmidt F, Zimmermann H, Mikolajczak J et al (2017) Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 11:45\u201350. \n                    https:\/\/doi.org\/10.1016\/j.msard.2016.11.008","journal-title":"Mult Scler Relat Disord"},{"key":"486_CR64","doi-asserted-by":"publisher","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151","volume":"8","author":"E Schneider","year":"2013","unstructured":"Schneider E, Zimmermann H, Oberwahrenbrock T et\u00a0al (2013) Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS ONE 8:e66151. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0066151","journal-title":"PLoS ONE"},{"key":"486_CR65","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","volume":"3","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda M, Armangu\u00e9 T, Sola-Valls N et al (2016) Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 3:e225. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000225","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijgo.2011.05.016","volume":"115","author":"W Shang","year":"2011","unstructured":"Shang W, Liu J (2011) Neuromyelitis optica during pregnancy. Int J Gynaecol Obstet 115:66\u201368. \n                    https:\/\/doi.org\/10.1016\/j.ijgo.2011.05.016","journal-title":"Int J Gynaecol Obstet"},{"key":"486_CR67","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1177\/1352458515583376","volume":"22","author":"Y Shimizu","year":"2016","unstructured":"Shimizu Y, Fujihara K, Ohashi T et al (2016) Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder. Mult Scler 22:1413\u20131420. \n                    https:\/\/doi.org\/10.1177\/1352458515583376","journal-title":"Mult Scler"},{"key":"486_CR68","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1212\/WNL.0b013e3182648bc8","volume":"79","author":"T Sinnecker","year":"2012","unstructured":"Sinnecker T, D\u00f6rr J, Pfueller CF et al (2012) Distinct lesion morphology at 7\u2011T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79:708\u2013714. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182648bc8","journal-title":"Neurology"},{"key":"486_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13167-015-0038-y","volume":"6","author":"T Sinnecker","year":"2015","unstructured":"Sinnecker T, Kuchling J, Dusek P et\u00a0al (2015) Ultrahigh field MRI in clinical neuroimmunology: a\u00a0potential contribution to improved diagnostics and personalised disease management. EPMA\u00a0J 6:16. \n                    https:\/\/doi.org\/10.1186\/s13167-015-0038-y","journal-title":"EPMA J"},{"key":"486_CR70","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1212\/NXI.0000000000000259","volume":"3","author":"T Sinnecker","year":"2016","unstructured":"Sinnecker T, Schumacher S, Mueller K et\u00a0al (2016) MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7\u202fT. Neurol Neuroimmunol Neuroinflamm 3:e259. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000259","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR71","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Gerdes LA, Krumbholz M et\u00a0al (2016) Autoantibodies to MOG in a\u00a0distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e257. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000257","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR72","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/jnnp-2017-315603","volume":"88","author":"J-P Stellmann","year":"2017","unstructured":"Stellmann J\u2011P, Krumbholz M, Friede T et al (2017) Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. J\u00a0Neurol Neurosurg Psychiatr 88:639\u2013647. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-315603","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"486_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.bbrc.2006.12.040","volume":"353","author":"X-L Sun","year":"2007","unstructured":"Sun X\u2011L, Ding J\u2011H, Fan Y et al (2007) Aquaporin 4 regulates the effects of ovarian hormones on monoamine neurotransmission. Biochem Biophys Res Commun 353:457\u2013462. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2006.12.040","journal-title":"Biochem Biophys Res Commun"},{"key":"486_CR74","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.fertnstert.2008.07.1785","volume":"92","author":"X-L Sun","year":"2009","unstructured":"Sun X\u2011L, Zhang J, Fan Y et al (2009) Aquaporin-4 deficiency induces subfertility in female mice. Fertil Steril 92:1736\u20131743. \n                    https:\/\/doi.org\/10.1016\/j.fertnstert.2008.07.1785","journal-title":"Fertil Steril"},{"key":"486_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx123","author":"C Thomas","year":"2017","unstructured":"Thomas C, Monteil-Ganiere C, Miralli\u00e9 S et al (2017) A severe neonatal lymphopenia associated with administration of azathioprine to the mother in a\u00a0context of Crohn\u2019s disease. J\u00a0Crohns Colitis. \n                    https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx123","journal-title":"J Crohns Colitis"},{"key":"486_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2014","unstructured":"Trebst C, Jarius S, Berthele A et\u00a0al (2014) Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J\u00a0Neurol 261:1\u201316. \n                    https:\/\/doi.org\/10.1007\/s00415-013-7169-7","journal-title":"J Neurol"},{"key":"486_CR77","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","volume":"92","author":"BG Weinshenker","year":"2017","unstructured":"Weinshenker BG, Wingerchuk DM (2017) Neuromyelitis spectrum disorders. Mayo Clin Proc 92:663\u2013679. \n                    https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.014","journal-title":"Mayo Clin Proc"},{"key":"486_CR78","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00115-012-3602-x","volume":"84","author":"B Wildemann","year":"2013","unstructured":"Wildemann B, Jarius S, Paul F (2013) Neuromyelitis optica. Nervenarzt 84:436\u2013441. \n                    https:\/\/doi.org\/10.1007\/s00115-012-3602-x","journal-title":"Nervenarzt"},{"key":"486_CR79","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2009.08.045","volume":"286","author":"DM Wingerchuk","year":"2009","unstructured":"Wingerchuk DM (2009) Neuromyelitis optica: effect of gender. J\u00a0Neurol Sci 286:18\u201323. \n                    https:\/\/doi.org\/10.1016\/j.jns.2009.08.045","journal-title":"J Neurol Sci"},{"key":"486_CR80","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","volume":"2","author":"SS Zamvil","year":"2015","unstructured":"Zamvil SS, Slavin AJ (2015) Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a\u00a0diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2:e62. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000062","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"486_CR81","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","volume":"2","author":"A Zekeridou","year":"2015","unstructured":"Zekeridou A, Lennon VA (2015) Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm 2:e110. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000110","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0486-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:42:22Z","timestamp":1548808942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0486-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0486-4","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"30 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Paul geh\u00f6rt dem wissenschaftlichen Beirat von Novartis an, erhielt Vortragshonorare und Reisekostenerstattungen von Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis\/Genzyme, Merck Serono, Alexion, Chugai, MedImmune und Shire, ist Academic Editor von PLoS One, ist Associate Editor von Neurology\u00ae Neuroimmunology & Neuroinflammation; \u00fcbte Beratert\u00e4tigkeiten f\u00fcr Sanofi-Genzyme, Biogen Idec, MedImmune, Shire und Alexion aus; erhielt Forschungsunterst\u00fctzung von Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis\/Genzyme, Alexion, Merck Serono, von der Deutschen Forschungsgemeinschaft, Werth Stiftung der Stadt K\u00f6ln, Bundesministerium f\u00fcr Bildung und Forschung, Arthur Arnstein Stiftung Berlin, EU FP7 Rahmenprogramm, Guthy Jackson Charitable Foundation und National Multiple Sclerosis of the USA. K.\u00a0Hellwig weist auf folgende Beziehungen hin: Beratert\u00e4tigkeiten und Vortragshonorare, sowie Forschungsunterst\u00fctzung  von Bayer Healthcare, Biogen, Novartis Pharma, Teva Pharma, Roche, Sanofi-Genzyme und Merck. N.\u00a0Borisow gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}